First Manhattan’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-5,153
| Closed | -$912K | – | 1533 |
|
|
2020
Q1 | $912K | Buy |
5,153
+111
| +2% | +$20.9K | 0.01% | 390 |
|
|
2019
Q4 | $963K | Sell |
5,042
-231
| -4% | -$41.7K | ﹤0.01% | 415 |
|
|
2019
Q3 | $887K | Sell |
5,273
-33,108
| -86% | -$5.39M | ﹤0.01% | 431 |
|
|
2019
Q2 | $6.43M | Sell |
38,381
-3,834
| -9% | -$531K | 0.04% | 204 |
|
|
2019
Q1 | $6.18M | Sell |
42,215
-5,591
| -12% | -$811K | 0.04% | 217 |
|
|
2018
Q4 | $6.39M | Sell |
47,806
-78,985
| -62% | -$12.9M | 0.04% | 212 |
|
|
2018
Q3 | $24.2M | Sell |
126,791
-1,850
| -1% | -$340K | 0.13% | 112 |
|
|
2018
Q2 | $21.4M | Sell |
128,641
-30,270
| -19% | -$4.86M | 0.12% | 120 |
|
|
2018
Q1 | $26.7M | Sell |
158,911
-70,584
| -31% | -$11.8M | 0.15% | 100 |
|
|
2017
Q4 | $37.5M | Buy |
229,495
+14,322
| +7% | +$2.57M | 0.21% | 83 |
|
|
2017
Q3 | $44.1M | Buy |
215,173
+42,210
| +24% | +$9.82M | 0.25% | 75 |
|
|
2017
Q2 | $42M | Buy |
172,963
+3,894
| +2% | +$915K | 0.25% | 76 |
|
|
2017
Q1 | $40.4M | Sell |
169,069
-662
| -0.4% | -$154K | 0.24% | 78 |
|
|
2016
Q4 | $35.6M | Sell |
169,731
-328,062
| -66% | -$68M | 0.22% | 89 |
|
|
2016
Q3 | $115M | Sell |
497,793
-196,243
| -28% | -$48M | 0.7% | 28 |
|
|
2016
Q2 | $160M | Buy |
694,036
+374,443
| +117% | +$86.3M | 0.99% | 20 |
|
|
2016
Q1 | $85.7M | Sell |
319,593
-336,654
| -51% | -$96.4M | 0.53% | 36 |
|
|
2015
Q4 | $205M | Buy |
656,247
+270,206
| +70% | +$80.4M | 1.26% | 20 |
|
|
2015
Q3 | $105M | Buy |
386,041
+137,501
| +55% | +$42.2M | 0.67% | 32 |
|
|
2015
Q2 | $75.4M | Buy |
248,540
+173,317
| +230% | +$51.7M | 0.45% | 42 |
|
|
2015
Q1 | $22.4M | Sell |
75,223
-344
| -0.5% | -$98.1K | 0.13% | 117 |
|
|
2014
Q4 | $19.5M | Sell |
75,567
-467
| -0.6% | -$117K | 0.11% | 124 |
|
|
2014
Q3 | $18.3M | Buy |
76,034
+73,534
| +2,941% | +$16.5M | 0.11% | 127 |
|
|
2014
Q2 | $557K | Hold |
2,500
| – | – | ﹤0.01% | 493 |
|
|
2014
Q1 | $514K | Buy |
+2,500
| New | +$495K | ﹤0.01% | 504 |
|
|
2013
Q4 | – | Sell |
-2,500
| Closed | -$360K | – | 1433 |
|
|
2013
Q3 | $360K | Hold |
2,500
| – | – | ﹤0.01% | 550 |
|
|
2013
Q2 | $336K | Buy |
+2,500
| New | +$283K | ﹤0.01% | 564 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
First Manhattan's AGN Position: Q2 2020 in Review
First Manhattan sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5,153 shares — an estimated $912K sold.
First Manhattan first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $205M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- First Manhattan reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- First Manhattan sold 5,153 Allergan plc shares in Q2 2020, an estimated $912K.
- First Manhattan first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
- First Manhattan's Allergan plc position peaked at $205M in Q4 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on First Manhattan's 13F filing for Q2 2020, filed 14 Aug 2020.